![Western Blot: ANP32B Antibody [NBP2-88766] - Host: Rabbit. Target Name: AN32B. Sample Type: MCF7 Whole Cell lysates. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/ANP32B-Antibody-Western-Blot-NBP2-88766-img0001.jpg "Western Blot: ANP32B Antibody [NBP2-88766] - Host: Rabbit. Target Name: AN32B. Sample Type: MCF7 Whole Cell lysates. Antibody Dilution: 1.0ug/ml")
| Reactivity | HuSpecies Glossary |
| Applications | WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Concentration | 0.5 mg/ml |
| Immunogen | The immunogen is a synthetic peptide directed towards the C-terminal region of Human ANP32B. Peptide sequence: LPQLTYLDGYDREDQEAPDSDAEVDGVDEEEEDEEGEDEEDEDDEDGEEE The peptide sequence for this immunogen was taken from within the described region. |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | ANP32B |
| Purity | Affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS, 2% Sucrose |
| Preservative | 0.09% Sodium Azide |
| Concentration | 0.5 mg/ml |
| Purity | Affinity purified |
![Flow Cytometry BCMA/TNFRSF17 Antibody [Unconjugated]](https://images.novusbio.com/images2/BCMA_AF193_Flow_Cytometry_19290.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for ANP32B Antibody (NBP2-88766)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | ANP32B |
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![N/A BAFF/BLyS/TNFSF13B [HRP]](https://images.novusbio.com/images2/BAFF_DBLYS0_ELISA_37.jpg)
![N/A BAFF/BLyS/TNFSF13B [HRP]](https://images.novusbio.com/images2/DATA_BAFF_DBLYS0_ELISA_589.jpg)
![Immunohistochemistry BAFFR/TNFRSF13C Antibody [Unconjugated]](https://images.novusbio.com/images2/BAFF_R_AF1162_Immunohistochemistry_23315.jpg)
![Flow Cytometry BAFFR/TNFRSF13C Antibody [Unconjugated]](https://images.novusbio.com/images2/BAFF_R_AF1162_Flow_Cytometry_18737.jpg)
![Neutralization BAFFR/TNFRSF13C Antibody [Unconjugated]](https://images.novusbio.com/images2/af1162_human-baff-r-tnfrsf13c-affinity-purified-polyclonal-ab-neutralization-115202015554.jpg)
![N/A APRIL/TNFSF13 [Biotin]](https://images.novusbio.com/images2/DATA_APRIL_DY884_ELISA_2333.jpg)
![N/A APRIL/TNFSF13 [Biotin]](https://images.novusbio.com/images2/DATA_APRIL_DY884_ELISA_2253.jpg)
![N/A CD40 Ligand/TNFSF5 [HRP]](https://images.novusbio.com/images2/CD40_Ligand_DCDL40_ELISA_60.jpg)
![N/A CD40 Ligand/TNFSF5 [HRP]](https://images.novusbio.com/images2/DATA_CD40_Ligand_DCDL40_ELISA_624.jpg)
![Immunocytochemistry Caspase-3 Antibody [Unconjugated] - Active](https://images.novusbio.com/images2/Caspase-3_AF835_Immunocytochemistry_6532.jpg)
![Immunohistochemistry Caspase-3 Antibody [Unconjugated] - Active](https://images.novusbio.com/images2/Caspase3_AF835_Immunohistochemistry_22976.jpg)
![Immunocytochemistry Caspase-3 Antibody [Unconjugated] - Active](https://images.novusbio.com/images2/Caspase-3_AF835_Immunocytochemistry_9340.jpg)
![Flow Cytometry CD83 Antibody (HB15e) [Unconjugated]](https://images.novusbio.com/images2/CD83_MAB1774_Flow_Cytometry_16153.jpg)
![Immunocytochemistry CD83 Antibody (HB15e) [Unconjugated]](https://images.novusbio.com/images2/CD83_MAB1774_Immunocytochemistry__Immunofluorescence_21639.jpg)
![Immunocytochemistry CD83 Antibody (HB15e) [Unconjugated]](https://images.novusbio.com/images2/CD83_MAB1774_Immunocytochemistry_6572.jpg)
![SDS-PAGE TWEAK/TNFSF12 [Unconjugated]](https://images.novusbio.com/images2/TWEAK_1090-TW_CF_655.jpg)
![Bioactivity TWEAK/TNFSF12 [Unconjugated]](https://images.novusbio.com/images2/TWEAK_1090-TW_CF_657.jpg)
![TRAIL/TNFSF10 [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "TRAIL/TNFSF10 [Unconjugated]")
![N/A IL-10 [Biotin]](https://images.novusbio.com/images2/DATA_IL10_DY417_ELISA_2014.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")